Loading...
Corrination of a GLP-1 Receptor Agonist for Glycemic Control without Emesis
Glucagon-like peptide-1 receptor (GLP-1R) agonists used to treat type 2 diabetes mellitus often produce nausea, vomiting, and in some patients, undesired anorexia. Notably, these behavioral effects are caused by direct central GLP-1R activation. Herein, we describe the creation of a GLP-1R agonist c...
Na minha lista:
| Udgivet i: | Cell Rep |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7376604/ https://ncbi.nlm.nih.gov/pubmed/32553160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2020.107768 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|